Bellerophon Therapeutics
BLPH
#11323
Rank
โ‚ฌ0.13 M
Marketcap
0,01090ย โ‚ฌ
Share price
-36.84%
Change (1 day)
-78.88%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): -0,83ย โ‚ฌ

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,76ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -18,80ย โ‚ฌ an increase over its 2016 EPS that were of -21,80ย โ‚ฌ.

EPS history for Bellerophon Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,83ย โ‚ฌ
2017-18,80ย โ‚ฌ-13.75%
2016-21,80ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
2,46ย โ‚ฌ-421.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-1,28ย โ‚ฌ 67.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
3,76ย โ‚ฌ-592.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
1,20ย โ‚ฌ-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA